SK15002003A3 - Použitie 3-[1-[2-(1-acetyl-2,3-dihydro-1H-indol-3-yl)etyl]- 1,2,3,6-tetrahydropyridín-4-yl]-6-chlór-1H-indolu - Google Patents
Použitie 3-[1-[2-(1-acetyl-2,3-dihydro-1H-indol-3-yl)etyl]- 1,2,3,6-tetrahydropyridín-4-yl]-6-chlór-1H-indolu Download PDFInfo
- Publication number
- SK15002003A3 SK15002003A3 SK1500-2003A SK15002003A SK15002003A3 SK 15002003 A3 SK15002003 A3 SK 15002003A3 SK 15002003 A SK15002003 A SK 15002003A SK 15002003 A3 SK15002003 A3 SK 15002003A3
- Authority
- SK
- Slovakia
- Prior art keywords
- indol
- dihydro
- acetyl
- chloro
- ethyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Recrystallisation Techniques (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200100732 | 2001-05-09 | ||
| PCT/DK2002/000298 WO2002089797A1 (en) | 2001-05-09 | 2002-05-07 | Treatment of adhd |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK15002003A3 true SK15002003A3 (sk) | 2004-05-04 |
Family
ID=8160484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1500-2003A SK15002003A3 (sk) | 2001-05-09 | 2002-05-07 | Použitie 3-[1-[2-(1-acetyl-2,3-dihydro-1H-indol-3-yl)etyl]- 1,2,3,6-tetrahydropyridín-4-yl]-6-chlór-1H-indolu |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7294638B2 (bg) |
| EP (1) | EP1387682A1 (bg) |
| JP (1) | JP2004528361A (bg) |
| KR (1) | KR20040007544A (bg) |
| CN (1) | CN1507351A (bg) |
| AR (1) | AR033287A1 (bg) |
| BG (1) | BG108400A (bg) |
| BR (1) | BR0209443A (bg) |
| CA (1) | CA2446652A1 (bg) |
| CO (1) | CO5540378A2 (bg) |
| CZ (1) | CZ20033197A3 (bg) |
| EA (1) | EA200301221A1 (bg) |
| HR (1) | HRP20030852A2 (bg) |
| HU (1) | HUP0400075A2 (bg) |
| IL (1) | IL158413A0 (bg) |
| IS (1) | IS6992A (bg) |
| MX (1) | MXPA03010136A (bg) |
| NO (1) | NO20034972L (bg) |
| NZ (1) | NZ528896A (bg) |
| PL (1) | PL367778A1 (bg) |
| SK (1) | SK15002003A3 (bg) |
| WO (1) | WO2002089797A1 (bg) |
| ZA (1) | ZA200307955B (bg) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003102097A1 (en) * | 2002-05-31 | 2003-12-11 | H. Lundbeck A/S | The hydrochloride of (s)-(+)-3-[1-[2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl]-1,2,3,6-tetrahydropyridin-4-yl]-6-chloro-1h-indole |
| AU2005299706A1 (en) * | 2004-10-22 | 2006-05-04 | Froimowitz, Mark | Methylphenidate analogs and methods of use thereof |
| EP2288362A4 (en) | 2008-04-19 | 2012-05-02 | Nisarga Biotech Pvt Ltd | PLANT-BASED COMPOSITION FOR DECREASING ADD / L ADHD, AND METHOD THEREOF |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5521197A (en) * | 1994-12-01 | 1996-05-28 | Eli Lilly And Company | 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists |
| ZA9711376B (en) * | 1996-12-20 | 1998-07-21 | Lundbeck & Co As H | Indole or dihydroindole derivatives |
| WO2002046156A2 (en) * | 2000-12-06 | 2002-06-13 | Sepracor, Inc. | 4,4-disubstituted piperidines for use as dopamine, serotonin and norepinephrine ligands |
-
2002
- 2002-04-29 AR ARP020101569A patent/AR033287A1/es not_active Application Discontinuation
- 2002-05-07 EP EP02724146A patent/EP1387682A1/en not_active Withdrawn
- 2002-05-07 PL PL02367778A patent/PL367778A1/xx not_active Application Discontinuation
- 2002-05-07 EA EA200301221A patent/EA200301221A1/ru unknown
- 2002-05-07 CZ CZ20033197A patent/CZ20033197A3/cs unknown
- 2002-05-07 WO PCT/DK2002/000298 patent/WO2002089797A1/en not_active Application Discontinuation
- 2002-05-07 CN CNA028095790A patent/CN1507351A/zh active Pending
- 2002-05-07 NZ NZ52889602A patent/NZ528896A/xx unknown
- 2002-05-07 BR BR0209443-6A patent/BR0209443A/pt not_active IP Right Cessation
- 2002-05-07 IL IL15841302A patent/IL158413A0/xx unknown
- 2002-05-07 JP JP2002586932A patent/JP2004528361A/ja active Pending
- 2002-05-07 SK SK1500-2003A patent/SK15002003A3/sk unknown
- 2002-05-07 HU HU0400075A patent/HUP0400075A2/hu unknown
- 2002-05-07 MX MXPA03010136A patent/MXPA03010136A/es unknown
- 2002-05-07 KR KR10-2003-7014554A patent/KR20040007544A/ko not_active Application Discontinuation
- 2002-05-07 CA CA002446652A patent/CA2446652A1/en not_active Abandoned
- 2002-05-07 US US10/477,382 patent/US7294638B2/en not_active Expired - Lifetime
-
2003
- 2003-10-13 IS IS6992A patent/IS6992A/is unknown
- 2003-10-13 ZA ZA200307955A patent/ZA200307955B/en unknown
- 2003-10-20 HR HR20030852A patent/HRP20030852A2/hr not_active Application Discontinuation
- 2003-11-07 NO NO20034972A patent/NO20034972L/no not_active Application Discontinuation
- 2003-11-27 CO CO03104809A patent/CO5540378A2/es not_active Application Discontinuation
- 2003-12-01 BG BG108400A patent/BG108400A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0400075A2 (hu) | 2004-04-28 |
| MXPA03010136A (es) | 2004-03-10 |
| JP2004528361A (ja) | 2004-09-16 |
| NO20034972D0 (no) | 2003-11-07 |
| IL158413A0 (en) | 2004-05-12 |
| CO5540378A2 (es) | 2005-07-29 |
| PL367778A1 (en) | 2005-03-07 |
| NZ528896A (en) | 2004-12-24 |
| US7294638B2 (en) | 2007-11-13 |
| AR033287A1 (es) | 2003-12-10 |
| US20040152737A1 (en) | 2004-08-05 |
| BR0209443A (pt) | 2004-08-03 |
| CA2446652A1 (en) | 2002-11-14 |
| IS6992A (is) | 2003-10-13 |
| EP1387682A1 (en) | 2004-02-11 |
| CZ20033197A3 (en) | 2004-06-16 |
| WO2002089797A8 (en) | 2004-03-25 |
| WO2002089797A1 (en) | 2002-11-14 |
| CN1507351A (zh) | 2004-06-23 |
| EA200301221A1 (ru) | 2004-04-29 |
| KR20040007544A (ko) | 2004-01-24 |
| HRP20030852A2 (en) | 2005-06-30 |
| ZA200307955B (en) | 2004-10-13 |
| BG108400A (bg) | 2004-11-30 |
| NO20034972L (no) | 2003-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DeBattista | Antidepressant agents | |
| JP5922515B2 (ja) | 線維筋痛症候群の長期治療のためのミルナシプラン | |
| AU2008283989B2 (en) | Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine receptor ligands. | |
| JPH02290872A (ja) | ５―クロロ―１―（４―フルオロフェニル） ―３―（１―（２― （２―イミダゾリジノン―１―イル）エチル） ―４―ピペリジル）―１ｈ―インドールまたはその薬学的に容認できる酸付加塩を使用する方法 | |
| LÉAN et al. | Beneficial effects of serotonin precursors in postanoxic action myoclonus | |
| JP2002226401A (ja) | うつ病の併用療法 | |
| Saletu-Zyhlarz et al. | Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients | |
| US20090203731A1 (en) | Treatment of depression and other affective disorders | |
| Hoerr et al. | Ensaculin (KA‐672. HCl): A Multitransmitter Approach to Dementia Treatment | |
| Fischhof et al. | Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID) | |
| SK15002003A3 (sk) | Použitie 3-[1-[2-(1-acetyl-2,3-dihydro-1H-indol-3-yl)etyl]- 1,2,3,6-tetrahydropyridín-4-yl]-6-chlór-1H-indolu | |
| US6849654B2 (en) | 5-methoxy-carbonylamino-N-acetyltryptamine compounds and derivates thereof | |
| Mori et al. | Effects of dopamine-and serotonin-related compounds on methamphetamine-induced self-injurious behavior in mice | |
| JP7134097B2 (ja) | 神経障害性疼痛の治療のための低用量ｆｌｔ３受容体阻害剤 | |
| US6239162B1 (en) | Method for treating depression | |
| JP2017061506A (ja) | 精神障害の治療における使用のためのイロペリドン代謝物 | |
| CN1216598C (zh) | 药物用途 | |
| MXPA06004382A (es) | Metodos y composiciones que comprenden talidomida para el tratamiento de fibromialgia. | |
| Gavras et al. | Safety and tolerability of eprosartan | |
| EP1942891B1 (en) | Novel combination of drugs as antidepressant | |
| KR20060130716A (ko) | 중추 신경계 질환을 치료 및 관리하기 위한 선택적사이토킨 억제성 약물을 사용하는 방법 및 이를 포함하는조성물 | |
| CN1247578C (zh) | 含有2－芳基－8－氧化二氢嘌呤衍生物作为活性成分的痴呆症治疗剂 | |
| AU2002254875A1 (en) | Treatment of ADHD | |
| WO1999064006A1 (en) | Use of a nk-1 receptor antagonist for treating psychiatric disorders | |
| US20090203738A1 (en) | Pharmaceutical Composition for Treating Bulimia and Depression Arising from Bulimia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB9A | Suspension of patent application procedure |